The biotechnology company reported $4.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.38 by $0.98.
The biotechnology company reported $4.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.38 by $0.98.
0 Comments